Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
about
Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectivesPotential targets for ovarian clear cell carcinoma: a review of updates and future perspectivesPathway-based classification of cancer subtypes.Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Adaptations to climate-mediated selective pressures in humans.Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα.Annexin A4 induces platinum resistance in a chloride-and calcium-dependent mannerRevealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arraysIdentification of Annexin A4 as a hepatopancreas factor involved in liver cell survival.Chemotherapeutic drug sensitivity of primary cultures of epithelial ovarian cancer cells from patients in relation to tumour characteristics and therapeutic outcome.An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.Inhibition of Raf-MEK-ERK and hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell lineComparative proteomics analysis of host cells infected with Brucella abortus A19.Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell linesPrognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancerQuantitative analysis of self-association and mobility of annexin A4 at the plasma membrane.A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma.Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review).Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers.Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer.Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line.A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cellsThe Fhit protein: an opportunity to overcome chemoresistance.Leucine-rich α-2 glycoprotein promotes lung fibrosis by modulating TGF-β signaling in fibroblasts.Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma.
P2860
Q26749280-4C138465-FDD2-46AE-9573-B9D294B079A5Q26775315-F41C8033-928C-4623-9F9E-7D720BB7C6E0Q30527843-30698AE9-2D36-436F-BADE-D75432A0F4F0Q33572313-32044CD9-C234-4732-B0B5-CFBF365F4F51Q33885950-BBC2AB71-156B-4AE3-911D-062414DD9638Q33889579-FF8D615B-217F-4087-B67A-E5479E5D5C6DQ34365873-66C77D80-EFA0-4583-9685-E8124170F53CQ34412619-D7BD1A6F-AFB2-42D5-B674-749685B5CE9BQ34496963-6AEB4486-FA44-4341-A9EF-B9A63B885BD8Q34742974-FDC6F365-EA10-4030-BAAE-EFF21666E393Q34751614-FF42A3B8-628F-42E3-AD4C-F07AF3DE74B4Q35020574-871670B5-4087-4142-BF9E-65E339B459FFQ35092488-884854C1-F14A-44A8-8D55-ECB84A9F1C2DQ35793694-2854E459-8BEE-4604-B35F-9EB5515ABC70Q36073404-16C72E1A-2CC8-41C9-8178-1D50FCE4ACBCQ36824485-77549661-76BA-4A61-B1BB-8E00F1EFBC36Q36847152-AAD7FB8F-3525-4092-88C6-8DA3A0C5E1CAQ37153741-718E4A2E-D323-4B4F-88CF-E792D4B22D7CQ37269461-CF11B170-80B8-482D-B7B8-95298D7BA64CQ37295775-F5CD7169-3770-40D7-8C7F-59B805CFC58AQ37296914-F00180E3-4DE2-40EF-98D5-E963F83C1B81Q37327379-7F5E6B43-DC0A-4251-85DB-BB8A7EEF9F08Q37776738-6517EA41-5C61-4B3F-BEAB-0DCEB02EB606Q38183430-E8EB9832-E0FD-412D-9870-032797A746CEQ38832323-BBADEADB-82E3-4998-9CA9-4380F40773AEQ39073167-5DAE3441-2620-44EC-8A08-269A306BA3CFQ39468037-54C501B0-62BC-4B06-BB6E-858A7FE5CEDBQ39837844-872F8B3D-0C7F-4972-9F1A-BDCDF3B0BB41Q40027839-FB1EA6B2-EC41-47C0-A920-2B74514AA153Q47115506-18B17379-7794-4453-872B-54E22637550DQ53205814-13A8454F-8626-4A95-BD3C-337C6674F455Q54321441-59F431E2-58AA-4525-B82F-F26F7C649501Q54705314-374F162F-73ED-4210-9E01-4D7B78B4A562
P2860
Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@ast
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@en
type
label
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@ast
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@en
prefLabel
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@ast
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@en
P2093
P50
P356
P1476
Enhanced expression of Annexin ...... hemoresistance to carboplatin.
@en
P2093
Barry Ripley
Chun Man Lee
Koji Morimoto
Masami Fujita
Tadashi Kimura
Takashi Miyatake
Takayuki Enomoto
Tsuyoshi Takahashi
Yutaka Ueda
P2860
P304
P356
10.1002/IJC.24587
P577
2009-11-01T00:00:00Z